Welcome To
Current Cancer Drug Targets

About the Journal

Aims & Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Editorial Board Members

Ranking and Category

140^th of 222 in ONCOLOGY

Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets"

Paul Workman
CRC Centre for Cancer Therapeutics, England

Announcements

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

The journal Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry publishes expert reviews, original research articles, drug clinical trial studies and special topic issues.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Combinatorial Chemistry & High Throughput Screening is a high impact factor journal, having an impact factor 1.041, and is indexed by all major indexing agencies.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

The journal Current Diabetes Reviews is essential reading for all researchers and clinicians who are involved in the field of diabetes.

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Targets is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Drug Delivery journal is essential reading for all pharmaceutical scientists involved in drug design, development and delivery.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Gene Therapy is a bi-monthly peer-reviewed journal, aimed at academic and industrial scientists, with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology.

The Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

The journal Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance.

Current Alzheimer Research publishes peer-reviewed reviews, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

CNS & Neurological Disorders - Drug Targets is a high impact factor journal and is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Drug Delivery & Formulation is essential reading for all researchers involved in the fields of drug delivery and formulation

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal Current Radiopharmaceuticals is essential reading for all the researchers involved in this field, and this journal is indexed by all the major indexing agencies

The journal publishes expert reviews, original research articles and thematic issues on molecular pharmacology

The journal Current Aging Science is essential reading for researchers, educators and physicians with interest in aging, age-related dementia and Alzheimer’s disease and longevity.

The Natural Products Journal a peer reviewed journal aims to publish all the latest and outstanding developments in natural products.

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

Related E-Books

Bentham ebook::Anti-Obesity Drug Discovery and Development

Bentham ebook::Glucose Homeostasis and Insulin Resistance

Bentham ebook::Epidemiology of Type 2 Diabetes

Bentham ebook::Phytotherapy in the Management of Diabetes and Hypertension

Bentham ebook::Frontiers in Clinical Drug Research – Diabetes and Obesity

Bentham ebook::Psychopharmacological Issues in Geriatrics

Bentham ebook::Frontiers in Computational Chemistry

Bentham ebook::Fundamentals of Systems Analysis and Modeling of Biosystems and Metabolism

Bentham ebook::Frontiers in Clinical Drug Research - Anti-Cancer Agents

Bentham ebook::Animated Atlas of Oncology

Bentham ebook::Frontiers in Anti-Cancer Drug Discovery

Bentham ebook::Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature

Bentham ebook::Topics in Anti-Cancer Research

Bentham ebook::Cancer Metastasis and Cancer Stem Cell/Niche

Bentham ebook::Avastin and Malignant Gliomas

Bentham ebook::Molecular Mechanism and Morphology in Cancer

Bentham ebook::Recent Advances in Angiogenesis and Antiangiogenesis

Bentham ebook::Theory in the Pathophysiology of Carcinogenesis

Bentham ebook::Multiple Myeloma - A New Era of Treatment Strategies

Bentham ebook::Molecular Aspects of Hepatocellular Carcinoma

Bentham ebook::Physiopathogenesis of Hematological Cancer

Bentham ebook::Molecular Oncology: Principles and Recent Advances

Bentham ebook::Advances in Cancer Drug Targets

Bentham ebook::Lung Cancer: Clinical and Surgical Specifications

Bentham ebook::Advances in Anticancer Agents in Medicinal Chemistry

Bentham ebook::Thyroid Cancer: A Clinical Overview and A Useful Laboratory Manual

Bentham ebook::Therapeutic Revolution The History of Medical Oncology from Early Days to the Creation of the Subspecialty

Bentham ebook::Cancer Immunotherapy: Mechanisms of Cancer Immunity, Engineering Immune-Based Therapies and Developing Clinical Trials

Bentham ebook::Malignant Pleural Mesothelioma: Present Status and Future Directions

About Publisher

Bentham Science: An Introduction

We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.

Subscription Information:

All Journals are available online. For information on the Journals and how to order, please visit our web site at: www.benthamscience.com/journal/price-order.php and select "Prices and Ordering" or contact our subscription department at: subscriptions@benthamscience.org

Open Access:

Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.